NLRP3 and viral infectious disease: Our findings provide the first direct evidence that similar processes occur in the lung in response to the Sars-Cov-2 E protein and document that this leads to suppression of the NLRP3 inflammasome, reduced IL-1β and IL-18 and decreased infiltration of the lung with macrophages under conditions mimicking the effects of viral infection.